Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page
- Check2 days agoChange DetectedThe study page content appears unchanged in its core details, with only minor layout or formatting differences visible in the screenshots.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check31 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference3%

- Check38 days agoChange DetectedUpdated version to v3.1.0 and added contact details (phones and emails); removed the old revision tag v3.0.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific drug information for Tislelizumab and the facility's name and location, while also removing previous location details and drug classifications.SummaryDifference2%

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.